KATHRYN WYATT: Open Payments
NPI 1245361831 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 54 payments from 13 companies in 2025. Trend: 2023 $245 · 2024 $901 · 2025 $1,283
Food & beverage: $1,249Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $266 |
| ARS Pharmaceuticals Operations, Inc. | 10 | $244 |
| Amgen Inc. | 9 | $191 |
| Regeneron Healthcare Solutions, Inc. | 8 | $155 |
| GENZYME CORPORATION | 4 | $131 |
| CSL Behring | 4 | $115 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Genentech USA, Inc. | 2 | $32 |
| Blueprint Medicines Corporation | 1 | $32 |
| Hikma Pharmaceuticals USA | 2 | $32 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, FASENRA, Hizentra, AYVAKIT, AIRSUPRA, Haegarda.
Industry payments across AL — which companies pay providers there.
